26-Hydroxycholesterol

26-Hydroxycholesterol is a lipid of Sterol Lipids (ST) class. 26-hydroxycholesterol is associated with abnormalities such as Cardiovascular Diseases, Vascular Diseases, Metabolic syndrome, Obesity and Fatty Streak, Arterial. The involved functions are known as Oxidation, phospholipase activity, glucose metabolism, Binding (Molecular Function) and Regulation. 26-hydroxycholesterol often locates in Immune system, Body tissue, Extracellular, Protoplasm and Back. The associated genes with 26-Hydroxycholesterol are Homologous Gene, chylomicron remnant, Receptor Gene, Alleles and D3 compound. The related lipids are 27-hydroxycholesterol, Hydroxycholesterols, Lysophosphatidylcholines, Total cholesterol and Lipopolysaccharides. The related experimental models are Knock-out and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of 26-Hydroxycholesterol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 26-Hydroxycholesterol?

26-Hydroxycholesterol is suspected in hypercholesterolemia, Obesity, Atherosclerosis, Metabolic syndrome, Neurodegenerative Disorders, Dyslipidemias and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 26-Hydroxycholesterol

MeSH term MeSH ID Detail
Inflammation D007249 119 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Alzheimer Disease D000544 76 associated lipids
Alcoholism D000437 27 associated lipids
Niemann-Pick Diseases D009542 25 associated lipids
Plaque, Amyloid D058225 19 associated lipids
Xanthomatosis, Cerebrotendinous D019294 14 associated lipids
Total 7

PubChem Associated disorders and diseases

What pathways are associated with 26-Hydroxycholesterol

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 26-Hydroxycholesterol?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 26-Hydroxycholesterol?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 26-Hydroxycholesterol?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 26-Hydroxycholesterol?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 26-Hydroxycholesterol?

Transgenic Model

Transgenic Model are used in the study 'Cholesterol and breast cancer pathophysiology.' (Nelson ER et al., 2014) and Transgenic Model are used in the study 'Obesity, cholesterol metabolism, and breast cancer pathogenesis.' (McDonnell DP et al., 2014).

Knock-out

Knock-out are used in the study 'The cholesterol metabolite 27-hydroxycholesterol promotes atherosclerosis via proinflammatory processes mediated by estrogen receptor alpha.' (Umetani M et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with 26-Hydroxycholesterol

Download all related citations
Per page 10 20 50 100 | Total 403
Authors Title Published Journal PubMed Link
Escher G et al. Role of CYP27A1 in progesterone metabolism in vitro and in vivo. 2009 Am. J. Physiol. Endocrinol. Metab. pmid:19671838
Li T and Chiang JY Regulation of bile acid and cholesterol metabolism by PPARs. 2009 PPAR Res pmid:19636418
Mateos L et al. Activity-regulated cytoskeleton-associated protein in rodent brain is down-regulated by high fat diet in vivo and by 27-hydroxycholesterol in vitro. 2009 Brain Pathol. pmid:18503570
Lütjohann D et al. 4beta-hydroxycholesterol as a marker of CYP3A4 inhibition in vivo - effects of itraconazole in man. 2009 Int J Clin Pharmacol Ther pmid:19954708
Wang Y et al. Targeted lipidomic analysis of oxysterols in the embryonic central nervous system. 2009 Mol Biosyst pmid:19381367
Zhou C et al. The steroid and xenobiotic receptor (SXR), beyond xenobiotic metabolism. 2009 Nucl Recept Signal pmid:19240808
Prasanthi JR et al. Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on beta-amyloid precursor protein levels and processing in human neuroblastoma SH-SY5Y cells. 2009 Mol Neurodegener pmid:19126211
Koschack J et al. Serum 24S-hydroxycholesterol and hippocampal size in middle-aged normal individuals. 2009 Neurobiol. Aging pmid:18061309
Mathieu JM et al. Medical bioremediation of age-related diseases. 2009 Microb. Cell Fact. pmid:19358742
Lange Y et al. Regulation of fibroblast mitochondrial 27-hydroxycholesterol production by active plasma membrane cholesterol. 2009 J. Lipid Res. pmid:19401598
van den Kommer TN et al. Total cholesterol and oxysterols: early markers for cognitive decline in elderly? 2009 Neurobiol. Aging pmid:17888546
Honda A et al. Highly sensitive quantification of key regulatory oxysterols in biological samples by LC-ESI-MS/MS. 2009 J. Lipid Res. pmid:18815436
Kölsch H et al. Alterations of cholesterol precursor levels in Alzheimer's disease. 2010 Biochim. Biophys. Acta pmid:20226877
Blom T et al. FTY720 stimulates 27-hydroxycholesterol production and confers atheroprotective effects in human primary macrophages. 2010 Circ. Res. pmid:20056921
Wang YM et al. The mechanism of dietary cholesterol effects on lipids metabolism in rats. 2010 Lipids Health Dis pmid:20070910
Dasari B et al. The oxysterol 27-hydroxycholesterol increases β-amyloid and oxidative stress in retinal pigment epithelial cells. 2010 BMC Ophthalmol pmid:20836858
Berrodin TJ et al. Identification of 5α, 6α-epoxycholesterol as a novel modulator of liver X receptor activity. 2010 Mol. Pharmacol. pmid:20837678
Kumari U and Heese K Cardiovascular dementia - a different perspective. 2010 Open Biochem J pmid:20448820
Crow JA et al. Inhibition of carboxylesterase activity of THP1 monocytes/macrophages and recombinant human carboxylesterase 1 by oxysterols and fatty acids. 2010 Biochim. Biophys. Acta pmid:19761868
DuSell CD et al. The endogenous selective estrogen receptor modulator 27-hydroxycholesterol is a negative regulator of bone homeostasis. 2010 Endocrinology pmid:20501668
Ullrich C et al. Hypercholesterolemia in rats impairs the cholinergic system and leads to memory deficits. 2010 Mol. Cell. Neurosci. pmid:20696249
Marwarha G et al. Leptin reduces the accumulation of Abeta and phosphorylated tau induced by 27-hydroxycholesterol in rabbit organotypic slices. 2010 J. Alzheimers Dis. pmid:20157255
Sniderman AD et al. Regulation of plasma LDL: the apoB paradigm. 2010 Clin. Sci. pmid:19922416
Jenner AM et al. The effect of APOE genotype on brain levels of oxysterols in young and old human APOE epsilon2, epsilon3 and epsilon4 knock-in mice. 2010 Neuroscience pmid:20416362
Taylor JM et al. Overexpression of steroidogenic acute regulatory protein increases macrophage cholesterol efflux to apolipoprotein AI. 2010 Cardiovasc. Res. pmid:20083572
Weingärtner O et al. An alternative pathway of reverse cholesterol transport: the oxysterol 27-hydroxycholesterol. 2010 Atherosclerosis pmid:19801147
Seet RC et al. Oxidative damage in Parkinson disease: Measurement using accurate biomarkers. 2010 Free Radic. Biol. Med. pmid:19969070
Schüle R et al. Marked accumulation of 27-hydroxycholesterol in SPG5 patients with hereditary spastic paresis. 2010 J. Lipid Res. pmid:19812052
Crisafulli C et al. Effects of Liver x receptor agonist treatment on signal transduction pathways in acute lung inflammation. 2010 Respir. Res. pmid:20175894
Greenhill C Bone: High 27-hydroxycholesterol decreases BMD. 2010 Nat Rev Endocrinol pmid:20803803
Schneider H et al. A novel mutation in the sterol 27-hydroxylase gene of a woman with autosomal recessive cerebrotendinous xanthomatosis. 2010 Orphanet J Rare Dis pmid:20925952
Akram A et al. Increased expression of RXRα in dementia: an early harbinger for the cholesterol dyshomeostasis? 2010 Mol Neurodegener pmid:20843353
Seet RC et al. Markers of oxidative damage are not elevated in otherwise healthy individuals with the metabolic syndrome. 2010 Diabetes Care pmid:20185735
Grinberg LT and Thal DR Vascular pathology in the aged human brain. 2010 Acta Neuropathol. pmid:20155424
Vallim T and Salter AM Regulation of hepatic gene expression by saturated fatty acids. 2010 Apr-Jun Prostaglandins Leukot. Essent. Fatty Acids pmid:20227267
Bełtowski J and Semczuk A Liver X receptor (LXR) and the reproductive system--a potential novel target for therapeutic intervention. 2010 Jan-Feb Pharmacol Rep pmid:20360612
Ebrahimi KB and Handa JT Lipids, lipoproteins, and age-related macular degeneration. 2011 J Lipids pmid:21822496
Honda A et al. Cholesterol 25-hydroxylation activity of CYP3A. 2011 J. Lipid Res. pmid:21576599
Vejux A et al. Contribution of cholesterol and oxysterols in the physiopathology of cataract: implication for the development of pharmacological treatments. 2011 J Ophthalmol pmid:21577274
Mateos L et al. Side chain-oxidized oxysterols regulate the brain renin-angiotensin system through a liver X receptor-dependent mechanism. 2011 J. Biol. Chem. pmid:21628469
Coomes E et al. Methotrexate in atherogenesis and cholesterol metabolism. 2011 Cholesterol pmid:21490773
Zhang JH et al. The N-terminal domain of NPC1L1 protein binds cholesterol and plays essential roles in cholesterol uptake. 2011 J. Biol. Chem. pmid:21602275
Dasari B et al. Cholesterol-enriched diet causes age-related macular degeneration-like pathology in rabbit retina. 2011 BMC Ophthalmol pmid:21851605
Ramírez C et al. ApoB100/LDLR-/- hypercholesterolaemic mice as a model for mild cognitive impairment and neuronal damage. 2011 PLoS ONE pmid:21829488
Pachikian BD et al. Hepatic n-3 polyunsaturated fatty acid depletion promotes steatosis and insulin resistance in mice: genomic analysis of cellular targets. 2011 PLoS ONE pmid:21853118
Makoukji J et al. Interplay between LXR and Wnt/β-catenin signaling in the negative regulation of peripheral myelin genes by oxysterols. 2011 J. Neurosci. pmid:21715627
Salomone S and Waeber C Selectivity and specificity of sphingosine-1-phosphate receptor ligands: caveats and critical thinking in characterizing receptor-mediated effects. 2011 Front Pharmacol pmid:21687504
Marwarha G et al. Molecular interplay between leptin, insulin-like growth factor-1, and β-amyloid in organotypic slices from rabbit hippocampus. 2011 Mol Neurodegener pmid:21651786
Bigalke B et al. Adipocytokines and CD34 progenitor cells in Alzheimer's disease. 2011 PLoS ONE pmid:21633502
Bowden KL et al. Lysosomal acid lipase deficiency impairs regulation of ABCA1 gene and formation of high density lipoproteins in cholesteryl ester storage disease. 2011 J. Biol. Chem. pmid:21757691